rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-3-1
|
pubmed:abstractText |
To investigate the effect of different S-mephenytoin 4'-hydroxylase (CYP2C19) genotype on the eradication rate of Helicobacter pylori (Hp) by different rabeprazole-based triple therapy in Chinese.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...,
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C19 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Mixed Function Oxygenases,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole,
http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0578-1426
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14990013-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:14990013-Adult,
pubmed-meshheading:14990013-Amoxicillin,
pubmed-meshheading:14990013-Anti-Ulcer Agents,
pubmed-meshheading:14990013-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:14990013-Benzimidazoles,
pubmed-meshheading:14990013-China,
pubmed-meshheading:14990013-Clarithromycin,
pubmed-meshheading:14990013-Drug Therapy, Combination,
pubmed-meshheading:14990013-Female,
pubmed-meshheading:14990013-Genotype,
pubmed-meshheading:14990013-Helicobacter Infections,
pubmed-meshheading:14990013-Helicobacter pylori,
pubmed-meshheading:14990013-Humans,
pubmed-meshheading:14990013-Logistic Models,
pubmed-meshheading:14990013-Male,
pubmed-meshheading:14990013-Middle Aged,
pubmed-meshheading:14990013-Mixed Function Oxygenases,
pubmed-meshheading:14990013-Omeprazole,
pubmed-meshheading:14990013-Polymorphism, Genetic,
pubmed-meshheading:14990013-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
[Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese].
|
pubmed:affiliation |
Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China. xingxianghe@hotmail.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|